ATAI
Price
$1.46
Change
+$0.07 (+5.04%)
Updated
Jan 17 closing price
Capitalization
244.99M
68 days until earnings call
VNDA
Price
$4.36
Change
-$0.08 (-1.80%)
Updated
Jan 17 closing price
Capitalization
254.22M
18 days until earnings call
Ad is loading...

ATAI vs VNDA

Header iconATAI vs VNDA Comparison
Open Charts ATAI vs VNDABanner chart's image
ATAI Life Sciences
Price$1.46
Change+$0.07 (+5.04%)
Volume$961.55K
Capitalization244.99M
Vanda Pharmaceuticals
Price$4.36
Change-$0.08 (-1.80%)
Volume$330.16K
Capitalization254.22M
ATAI vs VNDA Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. VNDA commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and VNDA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ATAI: $1.46 vs. VNDA: $4.36)
Brand notoriety: ATAI and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 52% vs. VNDA: 55%
Market capitalization -- ATAI: $244.99M vs. VNDA: $254.22M
ATAI [@Biotechnology] is valued at $244.99M. VNDA’s [@Biotechnology] market capitalization is $254.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATAI and VNDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 5 TA indicator(s) are bullish while VNDA’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 5 bullish, 5 bearish.
  • VNDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ATAI and VNDA are a good buy in the short-term.

Price Growth

ATAI (@Biotechnology) experienced а -2.67% price change this week, while VNDA (@Biotechnology) price change was -5.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

ATAI is expected to report earnings on May 20, 2025.

VNDA is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($254M) and ATAI($245M) have the same market capitalization . ATAI YTD gains are higher at: 9.774 vs. VNDA (-8.977). VNDA has higher annual earnings (EBITDA): -30.16M vs. ATAI (-124.33M). VNDA has more cash in the bank: 376M vs. ATAI (85.9M). VNDA has less debt than ATAI: VNDA (7.94M) vs ATAI (23.8M). VNDA has higher revenues than ATAI: VNDA (191M) vs ATAI (331K).
ATAIVNDAATAI / VNDA
Capitalization245M254M96%
EBITDA-124.33M-30.16M412%
Gain YTD9.774-8.977-109%
P/E RatioN/A137.00-
Revenue331K191M0%
Total Cash85.9M376M23%
Total Debt23.8M7.94M300%
FUNDAMENTALS RATINGS
ATAI vs VNDA: Fundamental Ratings
ATAI
VNDA
OUTLOOK RATING
1..100
7671
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9890
PRICE GROWTH RATING
1..100
5361
P/E GROWTH RATING
1..100
172
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATAI's Valuation (79) in the Miscellaneous Commercial Services industry is in the same range as VNDA (84) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VNDA’s over the last 12 months.

ATAI's Profit vs Risk Rating (100) in the Miscellaneous Commercial Services industry is in the same range as VNDA (100) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (90) in the Biotechnology industry is in the same range as ATAI (98) in the Miscellaneous Commercial Services industry. This means that VNDA’s stock grew similarly to ATAI’s over the last 12 months.

ATAI's Price Growth Rating (53) in the Miscellaneous Commercial Services industry is in the same range as VNDA (61) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's P/E Growth Rating (2) in the Biotechnology industry is in the same range as ATAI (17) in the Miscellaneous Commercial Services industry. This means that VNDA’s stock grew similarly to ATAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAIVNDA
RSI
ODDS (%)
Bearish Trend 5 days ago
81%
Bullish Trend 5 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
79%
Momentum
ODDS (%)
Bullish Trend 5 days ago
84%
Bearish Trend 5 days ago
80%
MACD
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
75%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 16 days ago
68%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 5 days ago
77%
Aroon
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
76%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+5.04%
NTLA - ATAI
46%
Loosely correlated
+0.85%
FATE - ATAI
45%
Loosely correlated
+1.60%
MNMD - ATAI
45%
Loosely correlated
+9.91%
ABCL - ATAI
45%
Loosely correlated
+1.02%
CRSP - ATAI
44%
Loosely correlated
+0.57%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with IKNA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
-1.80%
IKNA - VNDA
37%
Loosely correlated
-0.66%
SNGX - VNDA
32%
Poorly correlated
+3.52%
NTLA - VNDA
32%
Poorly correlated
+0.85%
ATAI - VNDA
31%
Poorly correlated
+5.04%
REPL - VNDA
30%
Poorly correlated
-2.12%
More